This document provides comprehensive, evidence-based recommendations for the management of stable ischemic heart disease.
Answers are grounded in this paper and cite their sources.
Directs evidence-based care for stable ischemic heart disease now; extends trial data into actionable recommendations.
Description: The American College of Physicians (ACP) developed this guideline with the American College of Cardiology Foundation (ACCF), American Heart Association (AHA), American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, and Society of Thoracic Surgeons to present the available evidence on the management of stable known or suspected ischemic heart disease. Methods: Literature on this topic published before November 2011 was identified by using MEDLINE, Embase, Cochrane CENTRAL, PsychINFO, AMED, and SCOPUS. Searches were limited to human studies published in English. This guideline grades the evidence and recommendations according to a translation of the ACCF/AHA grading system into ACP's clinical practice guidelines grading system. Recommendations: The guideline includes 48 specific recommendations that address the following issues: patient education, management of proven risk factors (dyslipidemia, hypertension, diabetes, physical activity body weight, and smoking), risk factor reduction strategies of unproven benefit, medical therapy to prevent myocardial infarction and death and to relieve symptoms, alternative therapy, revascularization to improve survival and symptoms, and patient follow-up.
No takes yet. Share an insight, caveat, or question.
Amir Qaseem (2012) conducted a review in Stable known or suspected ischemic heart disease. Clinical practice guideline for management of stable ischemic heart disease was evaluated on 48 specific recommendations addressing patient education, risk factors, medical therapy, alternative therapy, revascularization, and follow-up. The clinical practice guideline provides 48 specific recommendations for the management of stable known or suspected ischemic heart disease, including medical therapy and revascularization.
Synapse has enriched 10 related papers. Consider them for comparative context: